Two area women are among the first to donate blood plasma in an emergency clinical trial to help treat severely ill patients battling COVID-19

The project is part of the National COVID-19 Convalescent Plasma Project, which the Food and Drug Administration has approved as an Emergency Investigational New Drug (EIND).
Source: SUNY Upstate Medical - Category: Universities & Medical Training Tags: News Coronavirus Source Type: news